United States of America based
Quertle has developed unique AI solutions with predictive visual analytics to address the difficulties in discovering and understanding biomedical text content. It's BioAI™ (biomedical-specific AI) platform enables at least ten-fold deeper and at least 30-times more efficient discovery reducing R&D dead-ends, optimizing clinical trials, speeding products to market, identifying treatment options, and much more. With its AI predictive visual analytics based on the actual text meaning, products built on the BioAI platform provide intuitive means to explore complex content and the ability to make serendipitous discoveries.
TechnologiesAI Companies (Drug Discovery)
No pipelines published yet
No services posted yet